Skip to content

Role of Ultrasound based Venous congestion Assessment (VTI VEXUS Index) in predicting survival in critically ill patients with septic shock.

VTI VEXUS Index as a predictor of mortality in septic shock patients-A prospective observational study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112585
Enrollment
80
Registered
2026-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B- Imaging

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Koovakattil Akhil Kuttan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (more than 18 years old and less than 65 yrs old) diagnosed with septic shock based on Sepsis-3 criteria within 24 h of ICU admission and expected to stay for more than or equal to 72 hrs with atleast one feature of end-organ dysfunction: Acute kidney injury (AKI) of at least KDIGO criteria for AKI stage 1. Glasgow Coma Scale less than15 (GCS). Serum Lactate more than or equal to 2.0 mmol/L. Need for mechanical ventilation.

Exclusion criteria

Exclusion criteria: Patients with chronic liver disease and chronic kidney disease. Patients with limitations on life support interventions. Those who had undergone liver and renal transplantation. Pregnant patients. Unable to measure parameters due to suboptimal ECHO or VEXUS window. Patients with known cardiac valvular dysfunction. Patients with pre-existing end-stage renal disease requiring dialysis. Patient who denies consent. Death within 72 hours of study. Patients with known pulmonary artery hypertension.

Design outcomes

Primary

MeasureTime frame
predict 30 day mortality in critically ill patients with septic shock.Timepoint: Outcome will assessed /estimated at 30 days from ICU admission.

Secondary

MeasureTime frame
Duration of mechanical ventilation. Requirement & duration of vasopressor or ionotrope therapy. Major Adverse Kidney Event 30 (MAKE 30)- a composite of death, new renal replacement therapy (RRT), or persistent renal dysfunction (PRD) ICU & hospital length of stay. Multiorgan dysfunction score (MODS). Timepoint: Outcome will be assessed on day 30 of ICU admission

Countries

India

Contacts

Public ContactDr Suhail Sarwar Siddiqui

King George Medical university

sarwarsuhail@gmail.com9167584741

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026